Atlas FDA

VITAGEL SURGICAL HEMOSTAT

FDA premarket approval P050044/S021 · decided 2013-10-11

Approval details

PMA number
P050044
Supplement
S021
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
VITAGEL SURGICAL HEMOSTAT
Generic name
Agent, absorbable hemostatic, collagen based
Applicant
Stryker Corp.
Date received
2011-10-27
Decision date
2013-10-11
Days to decision
715 days
Decision code
APPR
Product code
LMF
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Kalamazoo, MI
Statement
APPROVAL FOR A NEW VERSION OF VITAGEL WHERE THE BOVINE THROMBIN COMPONENT IS REPLACED WITH RECOMBINANT HUMAN THROMBIN. THE PRODUCT, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME VITAGEL RT AND IS INDICATED IN SURGICAL PROCEDURES (OTHER THAN NEUROSURGICAL AND OPHTHALMIC) AS AN ADJUNCT TO HEMOSTASIS WHEN CONTROL OF BLEEDING BY LIGATURE OR CONVENTIONAL PROCEDURES IS INEFFECTIVE OR IMPRACTICAL.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
HipCheck (K230045)Stryker Corp.2023-09-29
Stryker CrossFlow Integrated Arthroscopy Pump (K191259)Stryker Corp.2019-07-12
HipCheck (K182359)Stryker Corp.2018-12-13
Stryker Footed Attachments and Cutting Accessories (K143399)Stryker Corp.2015-05-08
Stryker Elite Attachments, Stryker Heavy Duty (HD) Attachments (K143320)Stryker Corp.2015-04-23
LITe Plate System (K150449)Stryker Corp.2015-03-20
Xia 3 Spinal System (K142381)Stryker Corp.2014-10-21
ICONIX ALL SUTURE ANCHORS (K133671)Stryker Corp.2014-02-28